SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : EXTI - only public co. developing liver device
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Danny Kim who wrote ()11/5/1997 5:02:00 PM
From: Shay Berthelson  Read Replies (2) of 1063
 
Hi all,

I haven't posted much. I am new to this stock and have appreciated the communications that have been posted to this thread. I emailed Exten yesterday and received a respone today. The information may not be helpful to any of you. I wanted to let those who have not tried to communicate with the company, that they are accessible and helpful.

Attached is my email and Extens response.

Good luck all

To: extixeno@aol.com

Hello,My name is Shay Berthelson. I am a new investor in your company and was wondering about something. On your web site it states that Yale and Loyola already have a 4th generation Sybiol system. It also states in the most current press release that the company hopes to initiate clinical trials. I do not know much about
the industry. Is the clinical trial different from the animal studies? I was also curious if I could receive a copy of the Private Placement Memorandum.

Thanks
Shay B. Berthelson

Response:

Thank you for your investment and your interest. I will mail you the investor questionnaire and the private placement memorandum today. Phase one FDA clinical trials are the animal studies. After these are concluded successfully the later phases are human trials.

Barbara Corbett, Investor Relations.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News